Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022

SELL
$0.08 - $21.0 $1,748 - $458,850
-21,850 Reduced 26.73%
59,879 $4,000
Q2 2022

Aug 12, 2022

BUY
$0.16 - $0.47 $282 - $829
1,765 Added 2.21%
81,729 $14,000
Q1 2022

May 16, 2022

BUY
$0.42 - $0.62 $2,709 - $3,999
6,450 Added 8.77%
79,964 $38,000
Q4 2021

Feb 14, 2022

SELL
$0.56 - $1.71 $13,736 - $41,944
-24,529 Reduced 25.02%
73,514 $42,000
Q3 2021

Nov 15, 2021

SELL
$1.21 - $1.8 $12,730 - $18,937
-10,521 Reduced 9.69%
98,043 $163,000
Q2 2021

Aug 13, 2021

BUY
$1.56 - $1.98 $71,625 - $90,909
45,914 Added 73.29%
108,564 $181,000
Q1 2021

May 14, 2021

SELL
$1.36 - $2.49 $7,344 - $13,446
-5,400 Reduced 7.94%
62,650 $106,000
Q4 2020

Feb 12, 2021

SELL
$0.75 - $2.76 $9,937 - $36,570
-13,250 Reduced 16.3%
68,050 $108,000
Q3 2020

Nov 09, 2020

BUY
$0.61 - $1.17 $2,928 - $5,616
4,800 Added 6.27%
81,300 $78,000
Q2 2020

Aug 13, 2020

SELL
$0.47 - $0.72 $11,280 - $17,280
-24,000 Reduced 23.88%
76,500 $49,000
Q1 2020

May 14, 2020

BUY
$0.36 - $0.74 $3,495 - $7,184
9,709 Added 10.69%
100,500 $42,000
Q3 2019

Nov 13, 2019

BUY
$0.38 - $0.52 $926 - $1,268
2,439 Added 2.76%
90,791 $45,000
Q2 2019

Aug 09, 2019

BUY
$0.39 - $0.7 $34,457 - $61,846
88,352 New
88,352 $34,000
Q3 2018

Nov 14, 2018

SELL
$0.44 - $3.02 $13,200 - $90,600
-30,000 Closed
0 $0
Q1 2018

May 15, 2018

BUY
$2.16 - $3.48 $3,888 - $6,264
1,800 Added 6.38%
30,000 $102,000
Q4 2017

Feb 14, 2018

BUY
$0.68 - $4.19 $19,176 - $118,158
28,200 New
28,200 $115,000
Q3 2017

Nov 14, 2017

SELL
$0.38 - $0.66 $3,876 - $6,732
-10,200 Closed
0 $0
Q2 2017

Aug 14, 2017

BUY
N/A
10,200
10,200 $5,000

Others Institutions Holding AMPE

# of Institutions
1
Shares Held
96.6K
Call Options Held
0
Put Options Held
0

About Ampio Pharmaceuticals, Inc.


  • Ticker AMPE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 226,287,008
  • Market Cap $2.26M
  • Description
  • Ampio Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of immunomodulatory therapies for the treatment of pain from osteoarthritis in the United States. Its product pipeline includes AP-013, an intra-articular injection, which is in phase III clinical trial for the treatment of osteoarthritis of the knee; AP-017, an...
More about AMPE
Track This Portfolio

Track Lpl Financial LLC Portfolio

Follow Lpl Financial LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lpl Financial LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lpl Financial LLC with notifications on news.